Diversified Trust Co Buys 16,664 Shares of MetLife, Inc. $MET

Key Points

• Diversified Trust Co increased its stake in MetLife, acquiring an additional 16,664 shares, resulting in a total holding of 31,602 shares worth approximately $2.54 million.
• MetLife reported earnings of $2.02 per share for the last quarter, falling short of analysts' expectations, with revenue down 2.7% year-over-year at $17.34 billion.
• The stock has seen significant analyst attention, with ratings varying from a "strong-buy" by Wolfe Research to a "neutral" by Piper Sandler, and an average price target of $94.64.

Diversified Trust Co increased its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 111.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,602 shares of the financial services provider's stock after purchasing an additional 16,664 shares during the quarter. Diversified Trust Co's holdings in MetLife were worth $2,541,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the business. Bell Bank bought a new stake in shares of MetLife in the second quarter worth about $267,000. IFM Investors Pty Ltd grew its stake in shares of MetLife by 6.7% in the second quarter. IFM Investors Pty Ltd now owns 134,784 shares of the financial services provider's stock worth $10,839,000 after purchasing an additional 8,458 shares during the last quarter. Carderock Capital Management Inc. bought a new stake in shares of MetLife in the second quarter worth about $80,000. Ferguson Wellman Capital Management Inc. grew its stake in shares of MetLife by 0.6% in the second quarter. Ferguson Wellman Capital Management Inc. now owns 171,273 shares of the financial services provider's stock worth $13,774,000 after purchasing an additional 1,006 shares during the last quarter. Finally, Polianta Ltd bought a new stake in shares of MetLife in the second quarter worth about $1,278,000. 94.99% of the stock is owned by institutional investors.

MetLife Price Performance

Shares of MET opened at $79.16 on Friday. The firm has a market cap of $52.64 billion, a PE ratio of 13.42, a P/E/G ratio of 0.71 and a beta of 0.87. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.57. The firm has a fifty day simple moving average of $78.30 and a two-hundred day simple moving average of $78.12. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $89.05.

MetLife (NYSE:MET - Get Free Report) last announced its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing analysts' consensus estimates of $2.32 by ($0.30). MetLife had a net margin of 5.83% and a return on equity of 19.88%. The company had revenue of $17.34 billion for the quarter, compared to analysts' expectations of $18.58 billion. During the same quarter in the prior year, the firm posted $2.28 earnings per share. MetLife's quarterly revenue was down 2.7% on a year-over-year basis. On average, equities analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 5th were given a dividend of $0.5675 per share. The ex-dividend date of this dividend was Tuesday, August 5th. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.9%. MetLife's payout ratio is presently 38.47%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Wolfe Research raised MetLife to a "strong-buy" rating in a research report on Tuesday, September 16th. Jefferies Financial Group lifted their price objective on MetLife from $100.00 to $103.00 and gave the company a "buy" rating in a research report on Monday, August 11th. UBS Group cut their price objective on MetLife from $94.00 to $91.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Piper Sandler cut MetLife from an "overweight" rating to a "neutral" rating and set a $84.00 price objective on the stock. in a research report on Friday. Finally, Wells Fargo & Company reaffirmed an "overweight" rating and set a $97.00 price objective (up from $94.00) on shares of MetLife in a research report on Thursday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, MetLife has an average rating of "Moderate Buy" and a consensus price target of $94.64.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.